A close look at aging (senescent) cells in ALS brain and spinal cord

High Resolution Profiling of Senescent Cells in ALS Brain and Spinal Cord

NIH-funded research St. Louis VA Medical Center · NIH-11506358

Researchers will map aged (senescent) cells in brain and spinal cord tissue from people with ALS to learn how those cells might drive disease progression.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionSt. Louis VA Medical Center NIH-funded
Lab location1 site (St. Louis, UNITED STATES)
Project IDNIH-11506358 on NIH RePORTER

What this research studies

This project uses donated postmortem brain and spinal cord tissue from people with ALS, accessed mainly through the VA ALS Brain Bank, and groups samples by whether they have TDP-43 protein clumps. Scientists will apply high-resolution GeoMx digital spatial profiling to measure genes and proteins in neurons and surrounding cells to detect signs of cellular senescence and harmful secreted factors. They will compare TDP-43–positive and TDP-43–negative samples to see if protein accumulation triggers a senescence response that could promote chronic tissue damage. The work aims to pinpoint specific cell types and molecular signals that could become targets for future therapies.

Who could benefit from this research

Good fit: Ideal candidates are people with ALS (especially veterans) who are willing to arrange postmortem donation of brain and spinal cord tissue to the VA biorepository.

Not a fit: People without ALS or those seeking immediate clinical treatments are unlikely to receive direct benefit from this postmortem tissue research.

Why it matters

Potential benefit: If successful, this work could identify cellular mechanisms to target — for example by removing or neutralizing senescent cells — that might slow ALS progression.

How similar studies have performed: Related animal and lab studies link senescent cells to neurodegeneration and show senolytic approaches can help in models, but high-resolution profiling of senescent neurons in human ALS tissue is relatively new.

Where this research is happening

St. Louis, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's DiseaseAmyotrophic Lateral Sclerosis Motor Neuron Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.